Once infiltrated into the tumor microenvironment, active Tregs overexpress inhibitory molecules CTLA-4, PD-1, TIM-3, LAG-3, and TIGIT, which together inhibit the antitumoral immune response (18–20). Here, CTLA4 is linked to neoplasm.